Featured cases //

Asacol Antitrust Litigation – United Food and Commercial Workers Unions and Employers Midwest Health Benefits Fund, et. al. v. Allergan, PLC
Asacol is an ulcerative colitis drug taken keep the chronic symptoms of irritable bowel syndrome in remission. In July 2013, a generic version of Asacol should have entered the market, however, because of defendants’ anticompetitive schemes to manipulate drug availability, a generic version does not exist and consumers are paying supracompetitive prices for the drug. Read more »

Archstone Litigation -- Stender v. Archstone Smith Operating Trust, et al.
On November 30, 2007, Wexler Wallace instituted litigation on behalf of a class of investors who had negotiated for securities with certain essential characteristics, only to see those characteristics stripped away through a merger transaction in which the investors had no say. The complaint alleges, among other things, breaches of fiduciary duty, breach of contract and civil conspiracy. Read more »

Featured Investigations //

Essure Litigation
Wexler Wallace LLP is currently evaluating cases on behalf of individuals who have been injured after being implanted with the Essure device. Essure is a means of permanent contraception for women which is marketed as a less expensive, easier and safer alternative to the permanent contraception/sterilization methods of the past. In reality, it has lead to vast, serious complications, including, but not limited to device migration, organ perforation, and the need for additional surgery. Read more »

Invokana Lawsuit
Wexler Wallace is currently representing individuals who are or have taken Invokana and experienced complications or side effects from taking the drug. The FDA has cautioned patients to be aware of the potential link between Invokana and diabetic ketoacidosis – a condition of high levels of acid accumulating in the blood. Read more »

Low-Testosterone "Low T" Lawsuit
Wexler Wallace represents men who have suffered serious side effects arising from the use of testosterone products, including heart attack, an increased risk of stroke, and blood clots. Read more »

Recent Blog Posts //

Is Starbucks’ Base Pay Increase Enough to Make a Difference?
07/22/2016
If you’ve been in a Starbucks recently, you’ve probably noticed that the atmosphere feels more chaotic than calm. Overworked employees in understaffed store...
Read more »

Roger Ailes and the Secrecy of Arbitration
07/20/2016
Mandatory arbitration is usually criticized, or defended, from the perspective of the parties involved in the dispute itself but an interesting point has been r...
Read more »

Generic Drug Labeling: FDA Provides Guidance For Label Updates
07/12/2016
Just over five years ago, in June 2011, the U.S. Supreme Court decided PLIVA, Inc. v. Mensing,[1] a case which has served to buffer generic drug makers from fai...
Read more »